Reconstitution, storage and stability of Semax: a practical guide

How to reconstitute Semax?

Reconstituting Semax simply means re-dissolving the lyophilised peptide powder back into liquid form so it can be measured and used. This is a process that requires a few specific materials and a steady hand, not some sort of specialised expertise.

Semax is supplied as a freeze-dried powder because peptides are far more stable in this dry form than once dissolved in water. As soon as liquid is added, the peptide's stability countdown begins, which is why this stage matters and which is why getting it right makes an actual difference to how well Semax will actually work afterwards.

The basic process involves drawing a specific volume of bacteriostatic water into a syringe, slowly injecting it down the side wall of the vial, not directly onto the powder, and then gently swirling the vial until everything dissolves into a clear solution. The water should never be injected with force, and the vial should never be shaken. Peptides have a delicate three-dimensional structure, and rough handling can damage this structure and reduce the peptide's effectiveness in the body. This is one of the more easily overlooked aspects of reconstitution, which really affects whether the final product performs as expected.

What do you need to reconstitute Semax?

The required materials are quite minimal: a vial of lyophilised Semax powder, bacteriostatic water—not plain sterile water, and definitely not tap water—a syringe suitable for drawing and measuring small volumes of liquid, and alcohol swabs for maintaining hygiene during the process.

Bacteriostatic water is particularly preferred over standard sterile water because it contains a small amount of benzyl alcohol as a preservative, which helps prevent bacterial growth in the solution for days or weeks when it is drawn from the same vial. Standard sterile water does not have this preservative, meaning that any solution reconstituted with it should ideally be used up much more quickly to avoid the risk of contamination.

A clean, well-lit workspace also has a greater significance than is usually thought. Wiping down the work surface, thoroughly washing your hands, and disinfecting the rubber stopper of both the bacteriostatic water vial and the Semax vial with alcohol before introducing any needle are basic, but essential, steps to prevent contamination of the solution.

How to reconstitute a Semax 10 mg vial?

For a 10 mg vial, the amount of bacteriostatic water added determines the final concentration. It's a matter of choosing your desired concentration, not of there being one correct amount.

Adding 2 millilitres of bacteriostatic water to a 10 mg vial yields a concentration of 5 milligrams per millilitre, or 5000 micrograms per millilitre. Adding 1 millilitre would give a more concentrated 10 mg/ml solution. Adding more water—say, 5 millilitres—results in a more dilute 2 mg/ml solution, which may actually make it easier to measure small doses, as larger, more easily read volumes are used for each dose.

The correct choice depends on how the solution is administered and the required precision for measuring individual doses. A more diluted solution generally makes it easier to draw accurate small doses with a standard insulin syringe, as a larger volume is used for the same amount of peptide.

How to reconstitute a 5 mg vial of Semax?

The same logic applies to a 5 mg vial, just on a smaller scale. Adding 1 millilitre of bacteriostatic water to a 5 mg vial results in 5 mg per millilitre, corresponding to the concentration example above. Adding 2 millilitres would result in 2.5 mg per millilitre. As the 5 mg vials contain less total peptide than the 10 mg vials, a smaller volume of water might be preferred to keep the concentration high enough and avoid working with inconveniently large injection or spray volumes per dose.

What are the most common mistakes people make when reconstituting Semax?

The most common mistake is to vigorously shake the vial to speed up dissolution, rather than gently swirling it. This can physically damage the peptide's structure and reduce its efficacy. Another common error is injecting the bacteriostatic water directly onto the powder with force, which creates excessive foaming and can similarly strain the peptide molecules. Aiming the needle stream at the wall of the vial and allowing the water to flow down is a gentler and more correct technique.

People also sometimes use plain sterile water instead of bacteriostatic one, not realising that the preservative is important for longer storage, or they skip proper disinfection of vial stoppers, introducing a risk of contamination from the very beginning.

Incorrect mathematical calculations are another common pitfall. Confusing milligrams with micrograms, or forgetting to account for the actual concentration when drawing up a dose can lead to you taking significantly more or significantly less than intended. Double-checking your unit conversions before drawing up a dose is a simple habit that completely prevents these kinds of mistakes.

How much bacteriostatic water should be added for different vial sizes?

There is no single, universally correct amount of bacteriostatic water to add. What matters is choosing a final concentration that makes the intended dosing both accurate and practically measurable. The table below shows commonly used reference points based on standard reconstitution practices for peptides of this size.

The pattern here is simple: the total milligrams divided by the water volume in millilitres gives the concentration in milligrams per millilitre. Choosing a higher water volume dilutes the solution and makes individual low-dose measurements more tolerant and accurate with a standard syringe, whereas a lower water volume concentrates.

How to calculate the final concentration?

The calculation is simple when the two key numbers are known: the total amount of peptide in the vial measured in micrograms, divided by the total volume of liquid added measured in millilitres, gives the concentration in micrograms per millilitre.

For example, a 10 mg (10,000 micrograms) vial reconstituted with 2 millilitres of bacteriostatic water gives 10,000 divided by 2, which is 5,000 micrograms per millilitre. Therefore, if the target dose is 300 micrograms, the required volume is 300 divided by 5,000, which is 0.06 millilitres. On a standard 1 millilitre (100 unit) insulin syringe, this would correspond to drawing up to approximately the 6 mark.

This type of calculation is precisely the same mathematics used in practically all reconstituted peptides, and becoming proficient with it is one of the more valuable skills for anyone working with peptide compounds in general, not just Semax.

What concentration setting would be best specifically for a nasal spray?

When administered intranasally, the goal is typically to find a concentration that allows the target dose to be conveniently delivered within a small, easily administered volume – usually in the range of 50–150 microlitres per nostril, as larger volumes tend to drip down the throat rather than being absorbed by the nasal mucosa.

Russian clinical formulations have historically used solutions of 0.1% (1 milligram per millilitre) and 1% (10 milligrams per millilitre), depending on the required dose [1]. When reconstituting a vial for intranasal use, working backwards from the intended daily dose and a convenient spray volume will indicate which concentration makes the most practical sense for the specific situation.

How to convert Semax powder into a nasal spray?

Making Semax nasal spray at home involves the same reconstitution process described above, followed by transferring the dissolved solution into a clean nasal spray applicator bottle, rather than simply drawing doses from the original vial with a syringe. After the powder is dissolved in bacteriostatic water using a gentle technique, the solution is drawn into a syringe and carefully transferred into a sterile, empty nasal spray bottle.

It's worth stating clearly that this whole process, while technically not difficult, requires real attention to sterility at every stage. It is essentially the creation of a pharmaceutical preparation under non-pharmaceutical conditions, and the margin for error regarding contamination warrants serious consideration, not a superficial approach.

What equipment is needed?

In addition to the basic reconstitution materials—bacteriostatic water, a syringe, and alcohol swabs—a clean, sterile nasal spray bottle or dropper designed for this purpose is specifically needed. These are sold separately from the peptide itself and come in different spray volumes per actuation, which is important as it affects dosage calculations.

A small kitchen scale capable of measuring to the milligram can be useful when working with raw powder, rather than a pre-measured vial, although most people working with Semax use vials that already state their total peptide content, eliminating this step.

Nootropics like Semax and Selank are not recommended for mixing in the same nasal spray due to potential instability and degradation of the compounds. It's advised to administer them separately. If you have specific concerns about their administration, consulting a healthcare professional is recommended.

If you combine both peptides in a single spray bottle, the process follows the same general reconstitution logic, performed separately for each peptide before combining, or by reconstituting both in the same bacteriostatic water for those comfortable with combined mathematics.

As no published studies have formally tested the chemical stability of Semax and Selank when mixed together in solution, combining them relies on the reasoning that both are simple, water-soluble heptapeptides with no apparent chemical incompatibilities—not because their combined stability has been directly studied and confirmed. Anyone opting to combine them should carefully track the combined concentration, as miscalculating the dosage of either peptide becomes more complicated when working with a mixed solution.

What type of nasal spray bottle should be used?

A pharmaceutical-grade nasal spray bottle - ideally one sold specifically for compounding or research use of peptides - is a suitable choice, rather than reusing a bottle that previously contained another product. Residue from the previous product could contaminate the new solution or react unpredictably with the peptide.

These bottles typically come in small volumes of 10–15 millilitres, with a metered spray pump delivering a consistent volume with each press, which is important for dosing consistency from one use to the next.

How to ensure sterility when making Semax nasal spray?

Sterility comes down to a few consistent habits used every time. Thorough hand washing before starting, wiping down your workspace, disinfecting the cap of each vial and the port of each bottle with alcohol before introducing a needle or transferring liquid, using a fresh sterile needle and syringe at each step rather than re-using one that has already touched another surface, and avoiding any direct contact between your hands or a non-sterile surface and the inside of a vial, syringe, or spray bottle – all of these are essential.

Working in an clean, dust-free environment, away from pets, open windows, or anything that could introduce airborne contaminants, is also a sensible precaution. None of this requires laboratory-grade equipment, but it does require consistent discipline, as one slip in technique can introduce a contaminant that ruins a whole batch.

How should Semax powder be stored?

Unreconstituted, lyophilised Semax powder should be stored in a cool, dry, dark place, with refrigeration generally recommended for extended storage. The dry powder form is considerably more stable than the reconstituted liquid form and can typically tolerate short periods at room temperature without significant degradation.

Lyophilised peptides are protected from many chemical processes – particularly hydrolysis, which is the breakdown of peptide bonds by water – that cause degradation once dissolved in liquid. This is precisely why manufacturers ship and store peptides as powder, rather than pre-dissolved solutions, whenever possible.

Keeping the vial away from direct light, temperature fluctuations and in its original sealed packaging until reconstitution are sensible practices to protect the integrity of the powder during storage before use.

Does Semax require refrigeration?

The lyophilised powder form is more tolerant of room temperature storage for shorter periods than is commonly assumed. Refrigeration, however – typically at 2–8 degrees Celsius, which is the standard temperature of a domestic refrigerator – is generally the recommended practice for both unopened powder intended for longer-term storage and, particularly, for any Semax already reconstituted into its liquid form.

Once water is added and the peptide is in solution, cooling becomes significantly more important as the dissolved peptide is now exposed to conditions conducive to degradation, and low temperatures significantly slow down the chemical reactions responsible for this breakdown.

Can Semax be stored at room temperature?

Unreconstituted powder can generally tolerate short periods at room temperature – for example, during shipping or brief handling – without major concern, as this aligns with how lyophilised peptides are typically transported. However, the ability to tolerate short periods at room temperature differs from being suitable for long-term storage at that temperature. For any extended storage periods, transferring the powder to refrigerated conditions is a more conservative and protective choice.

Reconstituted Semax solution is a different matter entirely. Once dissolved, leaving it at room temperature for an extended period significantly increases the risk of both chemical degradation and bacterial growth, and refrigerating the liquid form is considered standard practice rather than an optional precaution.

How should reconstituted Semax be stored?

After adding bacteriostatic water and dissolving the powder, the resulting solution should be refrigerated between uses, being removed only briefly for each dose and then quickly returned. The vial should remain tightly capped, kept away from light, and handled with aseptic technique each time a dose is drawn to avoid introducing contamination, which refrigeration alone will not prevent.

Some sources discuss freezing reconstituted peptide solutions for longer storage, but the freeze-thaw cycles themselves can strain the peptide's structure, and no published study has specifically validated freezing as a storage method for reconstituted Semax. Refrigeration remains a more conventional and better-supported approach for solutions intended for use within a reasonable timeframe.

What are the generally optimal storage conditions?

In summary, unopened lyophilised powder should be stored in the refrigerator, away from light and temperature fluctuations, in its original packaging. Reconstituted solution should be continuously stored in the refrigerator between doses, kept tightly sealed, and handled using aseptic technique.

This two-stage approach – protective storage before reconstitution, followed by more careful refrigerated storage after it – reflects the fundamental principle that the powdered form is inherently more stable, and the liquid form is where active protection against degradation truly matters.

How long does Semax powder last before reconstitution?

No published study has established a precise, validated shelf-life value for unreconstituted Semax powder under specified storage conditions. This means that any specific figure seen online — „18 months”, „2 years” and so on — should be understood as general industry practice for lyophilised peptides, rather than a figure specifically confirmed by formal stability testing of Semax itself.

What can be stated with certainty is that the dry, lyophilised form is considerably more stable than the reconstituted liquid form, and properly stored powder – chilled, sealed, protected from light – retains its integrity for a significantly longer period than the solution.

How long does reconstituted Semax last in the fridge?

This is another area where no published stability studies have established precise, scientifically validated timeframes specifically for reconstituted Semax. General guidelines circulating within peptide communities—typically suggesting a window of around 2–4 weeks for refrigerated reconstituted peptide solutions—reflect common practice for similar small peptides, rather than data generated specifically for Semax.

The preservative benzyl alcohol in bacteriostatic water does indeed help extend usefulness compared to plain sterile water, but it does not make the solution infinitely stable, and this preservative effect diminishes with storage time.

To be direct about this limitation: no published studies have established an exact stability period for reconstituted Semax solution. Anyone using reconstituted Semax should treat general peptide handling timelines as an approximate guide rather than a scientifically confirmed expiry point, and should rely on careful observation, discussed below, alongside reasonable caution against indefinite use.

Does Semax degrade over time and how can you tell?

Yes, peptides generally degrade over time in solution, through processes involving hydrolysis, oxidation, and bacterial contamination. Semax is no exception to these fundamental chemical realities.

Studies on the degradation of Semax itself, analysing how it breaks down in blood, brain tissue, and other biological environments, consistently show that it is cleaved by specific enzymes into smaller fragments, such as HFPGP and PGP, over time [2], [3]. Although these studies were conducted in biological tissue rather than a stored vial, they confirm that Semax is a degradable molecule under the right conditions, providing a reasonable basis to assume that gradual degradation may also occur during storage, particularly in solution.

Visual indicators that a reconstituted peptide solution may have degraded or become contaminated include cloudiness, discoloration, visible particles, or an unusual odour. Any of these signs should be a cue to discard the solution rather than continue its use, as there is no reliable way to verify the potency or safety of the peptide once these changes have occurred. The absence of these visual indicators, however, does not guarantee that the peptide still retains its full potency, as chemical degradation can occur without causing any visible change in the appearance of the solution.

How long does Semax nasal spray last after preparation?

Once transferred to a nasal spray bottle, the same general storage and shelf-life principles for the reconstituted solution apply. Refrigeration is recommended, and the solution should be used within the same general timeframe discussed above, rather than being treated as having an extended shelf life simply because it is now in a spray bottle rather than a vial. The spray mechanism itself does not add any preservative or stabilising benefit – it is simply a different method of delivering the same solution, with the same fundamental stability considerations.

What are the most common mistakes in storing Semax?

The most common mistake is leaving reconstituted Semax solution at room temperature for extended periods rather than promptly returning it to the refrigerator after each use. It’s easy to fall into this habit, especially if the refrigerator isn’t conveniently located, but it significantly speeds up degradation and increases the risk of contamination.

Another common mistake is storing the powder or solution in direct sunlight or near a window, unaware that light exposure can contribute to the breakdown of peptide structures over time. People also sometimes store Semax in the refrigerator door, which is actually one of the least temperature-stable locations in a fridge due to frequent opening and closing. Placing the vial further back on a shelf will provide more consistent temperature protection.

Can heat damage Semax?

Yes, heat accelerates the breakdown of peptide structures, which is precisely why cooling is recommended – low temperatures slow down the molecular motion and chemical reactions driving degradation.

Leaving Semax in a heated car, near a cooker, in direct summer sun, or anywhere where the temperature rises significantly above room temperature for any length of time, can measurably reduce its potency, even if the solution still looks completely normal. This is one of the more easily overlooked risks because heat damage is often not visible.

Can light damage Semax?

Exposure to light, particularly direct sunlight and UV radiation, is generally considered to contribute to the degradation of peptide compounds over time, which is why pharmaceutical peptide vials are typically supplied in amber or opaque packaging, rather than clear glass.

If the Semax vial or nasal spray bottle is clear, the extra step of storing it in a drawer, cupboard or other dark place – rather than on a countertop or windowsill – adds a layer of protection that costs nothing and significantly reduces one avoidable source of degradation.

What happens if Semax is not refrigerated?

If unconstituted powder spends a short time without refrigeration, this is generally tolerable and consistent with normal transport conditions. However, if the reconstituted solution remains unrefrigerated for an extended period, the most likely consequences are accelerated chemical degradation of the peptide itself, reducing its potency, alongside an increased risk of bacterial growth in the solution – which is a true safety as well as efficacy issue.

None of these consequences are necessarily visible to the naked eye, which is why proactively adhering to storage guidelines is more important than waiting to see obvious signs of a problem.

Does freezing damage Semax?

Freezing reconstituted peptide solutions is a more controversial practice than refrigeration, and no published studies have specifically validated freezing as a safe long-term storage method for reconstituted Semax.

The concern is that the freeze-thaw process itself can physically disrupt peptide structures through ice crystal formation, and repeated freeze-thaw cycles, in particular, are generally discouraged in broader peptide handling practices as each cycle introduces additional stress to the molecule. If freezing is used at all, it should be done once, with a single thaw before use, rather than repeatedly freezing and thawing the same vial.

Can Semax be transported without refrigeration?

Short transport without refrigeration – for example, a few hours during transit – is generally consistent with how lyophilised peptide powder is normally shipped and handled, and should not raise significant concerns specifically for the unconstituted form.

For longer travel periods, or for a reconstituted solution that needs to remain cold, using an insulated cool bag with a cold pack is a more careful approach, similar to how people transport other temperature-sensitive medications, such as insulin.

How to travel with Semax?

For shorter journeys, storing reconstituted Semax in an insulated travel bag with a small cooling element helps maintain the correct temperature during transport. For longer journeys or situations where refrigeration will not be available for many hours, travelling with the unreconstituted powder form instead of the pre-mixed solution is a more conservative choice, as the powder tolerates temperature fluctuations much better than the liquid form.

Fresh reconstitution upon arrival at the destination, where mains refrigeration is again available, avoids prolonged exposure without refrigeration that would be associated with travelling with a pre-mixed solution.

Disclaimer

This article is for educational and informational-scientific purposes only and should not be interpreted as medical advice, diagnosis, therapeutic recommendation, or instruction for preparing or self-administering any compound. Semax remains a research compound in most countries, including the United States and most European countries, and is not approved by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for the treatment of any medical condition. It is approved and used clinically in Russia and some Eastern European countries. Information on reconstitution and storage presented here reflects general practices for handling peptides and is not based on formal stability studies specific to Semax, unless otherwise stated. This content is not intended to guide or encourage self-administration.

References

[1] Polunin, G. S., Nurieva, S. M., Baiandin, D. L., Sheremet, N. L., & Andreeva, L. A. (2000). Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease. Journal of Ophthalmology, 116(1), 15–18. PMID: 10741256 https://pubmed.ncbi.nlm.nih.gov/10741256/ 

[2] Dolotov, O. V., Zolotarev, Yu. A., Dorokhova, E. M., Andreeva, L. A., Alfeeva, L. Yu., Grivennikov, I. A., & Miasoedov, N. F. (2004). The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation. Biochemical Chemistry, 30(3), 241–246. https://doi.org/10.1023/b:rubi.0000030127.46845.f0

[3] Zolotarev, Yu. A., Dadaian, A. K., Dolotov, O. V., Kozik, V. S., Kost, N. V., Sokolov, O. Yu., Dorokhova, E. M., Meshavkin, V. K., Inozemtseva, L. S., Gabaeva, M. V., Andreeva, L. A., Alfeeva, L. Yu., Pavlov, T. S., Badmaeva, K. E., Badmaeva, S. E., Bakaeva, Z. V., Kopylova, G. N., Samonina, G. E., Vas’kovsky, B. V., Grivennikov, I. A., Zozulia, A. A., & Myasoedov, N. F. (2006). Evenly tritium-labelled peptides and their in vivo and in vitro biodegradation. Bioorganic Chemistry, 32(2), 183–191. PMID: 16637290 https://pubmed.ncbi.nlm.nih.gov/16637290/